WEBINAR - Primary Packaging for Sensitive Biologic Injectables: A Cross-Functional Discussion Between UCB and Aptar Pharma

Gain a 360° perspective to inform confident packaging and supply decisions.

What creates confidence beyond the component specification?

For sensitive biologic injectables, primary-packaging decisions can affect product protection, manufacturing performance and continuity of supply.

Join experts from UCB and Aptar Pharma for a practical discussion on primary packaging for sensitive biologic injectables, with a focus on elastomeric closure components such as syringe plungers and vial stoppers. Hear how primary packaging, procurement and quality perspectives come together to inform component selection and long-term supply decisions.

Choose your session

Two sessions to accommodate different time zones. Choose the session that suits your schedule.

CLICK HERE TO REGISTER FOR SESSION 1 →

London 09:00 GMT · Paris 10:00 CET
Mumbai 14:30 IST · Shanghai 17:00 (UTC+8)

CLICK HERE TO REGISTER FOR SESSION 2 →

Los Angeles 07:00 PST · New York 10:00 EST
London 15:00 GMT · Paris 16:00 CET

The discussion will explore

What creates confidence in consistent component quality, including upstream controls and contamination control
How platform strategies can help reduce future qualification and implementation complexity
How manufacturing flexibility and multisourcing decisions influence supply resilience
What pharmaceutical companies should expect from a long-term packaging partner

Meet the Speakers